Form 4/A for BSX Boston Scientific
Accepted 2024-03-11 00:00:00 ET · period of report 2024-02-14 · accession 0001225208-24-004027 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2024-03-11 | 2024-02-14 | BSX | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | F - Tax | — | 0 | 28.6K | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-14 | F | D | 0 | $65.95 | 28,575.99 | D | — | — |